Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Selective relaxant binding agents

From Wikipedia, the free encyclopedia
(Redirected fromSelective relaxant binding agent)
icon
This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Selective relaxant binding agents" – news ·newspapers ·books ·scholar ·JSTOR
(November 2023) (Learn how and when to remove this message)

Selective relaxant binding agents (SRBAs) are a new class ofdrugs that selectively encapsulates and bindsneuromuscular blocking agents (NMBAs). The first drug introduction of an SRBA issugammadex. SRBAs exert achelating action that effectively terminates an NMBA ability to bind tonicotinic receptors.[1]

Examples of SRBAs include:

1. Sugammadex is a modified gamma cyclodextrin that specifically encapsulates and binds the aminosteroid NMBAs: affinity is highest forrocuronium, followed byvecuronium, and relatively low affinity forpancuronium.

2. Adamgammadex is also a modified gamma-cyclodextrin, with acetyl-amino groups replacing the carboxylic acid groups of sugammadex. Early research suggests it may have a lower incidence of adverse reactions than sugammadex[2][3]

3. Calabadion 1 and calabadion 2 are cucurbituril molecules with high binding affinity for both aminosteroid and benzylisoquinoline muscle relaxants.[4] Calabadion 2 has 89 times the affinity for rocuronium than does sugammadex.[5]

Discovery of SRBAs

[edit]

The discovery of SRBA as a new class of drug is the result of work done by Organon laboratories at theNewhouse research site inScotland.Cyclodextrins were explored as a means to solubilize rocuronium bromide (asteroidal NMBA) in a neutral aqueous solution. Upon creating numerous modified cyclodextrins, one particularmolecule was found to possess extremely high affinity for the rocuronium molecule. Originally known as Org25969, it is now generically named sugammadex sodium.

References

[edit]
  1. ^Naguib, Mohamed; Brull, Sorin J (January 2009)."Sugammadex: a novel selective relaxant binding agent".Expert Review of Clinical Pharmacology.2 (1):37–53.doi:10.1586/17512433.2.1.37.ISSN 1751-2433.PMID 24422770.S2CID 40625075.
  2. ^Jiang Y, Zhang Y, Zhu Z, Huang Y, Zhou D, Liu J, Li C, Chen X, Kang D, Wang S, Liu J, Liu B, Zhang W. (25 Nov 2022)."Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial".J Clin Med.11 (23): 6951.doi:10.3390/jcm11236951.PMC 9738056.PMID 36498526.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^Zhang Y, Jiang Y, Lei Q, Li C, Jin S, Wang Q, Huang Y, Li Y, Hong Y, Wang S, Lin H, Li H, Ou Y, Zou X, Sun Q, Guo Q, Chen Z, Min S, Qi Y, Jie Q, Liu J, Liu B, Zhang W. (Jan 2024)."Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block".Br J Anaesth.132 (1):45–52.doi:10.1016/j.bja.2023.10.022.PMID 38007377.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^Hoffmann U, Grosse-Sundrup M, Eikermann-Haerter K, Zaremba S, Ayata C, Zhang B, Ma D, Isaacs L, Eikermann M. (August 2013). "Calabadion: A new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents".Anesthesiology.119 (2):317–325.doi:10.1097/ALN.0b013e3182910213.PMID 23549405.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^Haerter F, Simons JC, Foerster U, Moreno Duarte I, Diaz-Gil D, Ganapati S, Eikermann-Haerter K, Ayata C, Zhang B, Blobner M, Isaacs L, Eikermann M. (Dec 2015)."Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents".Anesthesiology.123 (6):1337–1349.doi:10.1097/ALN.0000000000000868.PMC 4679413.PMID 26418697.{{cite journal}}: CS1 maint: multiple names: authors list (link)
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(andprodrugs)
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(andPAMsTooltip positive allosteric modulators)
Antagonists
(andNAMsTooltip negative allosteric modulators)
Precursors
(andprodrugs)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Selective_relaxant_binding_agents&oldid=1301206188"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp